ISB News

President Obama Presents National Medal of Science to Dr. Lee Hood

ISB NEWS

We have been celebrating Dr. Lee Hood’s National Medal of Science, which he received during a White House ceremony on Feb. 1. While the medal honors Lee’s career as a visionary scientist, we would like to thank all the past and current collaborators who have contributed to the success of not only Lee but of ISB, too. ISB has always valued collaboration across disciplines as well as between institutions; team science is necessary to push boundaries and achieve breakthroughs. During an interview on KING 5 Morning News on Feb. 4, Lee said this about the medal: “It’s an enormously exciting opportunity the idea that your whole career has been awarded, the idea that the colleagues you’ve worked with for so long have been, in a sense, rewarded.”

(If you can’t see this video, click on this link.)

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.